Pan‐immune‐inflammation value predicts immunotherapy response and reflects local antitumor immune response in rectal cancer
Cancer Science · 2025
DOI: 10.1111/cas.16400 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cancer Science, 2025. Verfasst von Qianyu Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, …. Hauptthemen laut MEDLINE: Rectal Neoplasms, Inflammation, Immunotherapy, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National High Level Hospital Clinical Research Funding, Natural Science Foundation in Beijing.
Abstract (Originalsprache)
The pan‐immune‐inflammation value reflects the systemic inflammatory response, and tumor‐infiltrating lymphocytes indicate a local immune response in rectal cancer. However, the association between systemic inflammatory response, as indicated by the pan‐immune‐inflammation value, and local immune responses in rectal cancer remains unclear. This study analyzed 915 treatment‐naïve rectal cancer patients from the Peking Union Medical College Hospital and PLA General Hospital (PLAGH) cohorts who underwent radical surgery to investigate the relationship between the pan‐immune‐inflammation value and immune responses. Lower pan‐immune‐inflammation value was significantly associated with improved disease‐free survival and cancer‐specific survival. Multivariate Cox regression models identified the pan‐immune‐inflammation value as an independent prognostic factor. In the PLAGH cohort, patients with low pan‐immune‐inflammation values had higher immune cell levels, activated immune pathways, and increased expression of immune checkpoint genes according to RNA sequencing. Hematoxylin and eosin staining and immunohistochemical analysis revealed that lower pan‐immune‐inflammation value was associated with higher tumor‐infiltrating lymphocyte density, more mature tertiary lymphoid structures, increased CD8 + T cells, and elevated human lymphocyte antigen class I expression. Conversely, patients with high pan‐immune‐inflammation values exhibited pathways linked to tumor progression, such as angiogenesis, epithelial–mesenchymal transition, hypoxia, KRAS signaling, and TGF‐ß signaling. Among patients receiving anti‐PD‐1 therapy, responders had low pre‐ and post‐treatment pan‐immune‐inflammation values. The pan‐immune‐inflammation value is a reliable marker associated with distinct immune microenvironment characteristics and can effectively predict disease‐free survival, cancer‐specific survival, and response to immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Medical Department of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
- Department of Pathology, The 7th Medical Center, Chinese PLA General Hospital, Beijing, China.
ORCID-Profile: Qianyu Wang
Förderung
- National High Level Hospital Clinical Research Funding
- Natural Science Foundation in Beijing
Zitieren
APA
Wang, Q., Zhong, W., Xiao, Y., Lin, G., Lu, J., Xu, L., Zhang, G., Liu, A., Du, J., & Wu, B. (2025). Pan‐immune‐inflammation value predicts immunotherapy response and reflects local antitumor immune response in rectal cancer. Cancer Science. https://doi.org/10.1111/cas.16400
Vancouver
Wang Q, Zhong W, Xiao Y, Lin G, Lu J, Xu L, et al. Pan‐immune‐inflammation value predicts immunotherapy response and reflects local antitumor immune response in rectal cancer. Cancer Science. 2025. doi:10.1111/cas.16400
BibTeX
@article{Wang2025,
author = {Wang, Qianyu and Zhong, Wentao and Xiao, Yi and Lin, Guole and Lu, Junyang and Xu, Lai and Zhang, Guannan and Liu, Aijun and Du, Junfeng and Wu, Bin},
title = {Pan‐immune‐inflammation value predicts immunotherapy response and reflects local antitumor immune response in rectal cancer},
journal = {Cancer Science},
year = {2025},
doi = {10.1111/cas.16400}
}
EUVIMED